Hempire

Hempire Technology Group is a biotechnology company founded in 2019 that specializes in the research and development of cannabinoid-based therapeutics for neurodegenerative disorders. Headquartered in Hong Kong with operations across Japan and mainland China, the company manages the full industrial hemp value chain, including cultivation, extraction, and clinical research. Hempire has secured key patents for cannabinoid compositions targeting Parkinson's and Alzheimer's diseases and maintains a strategic partnership with the Japanese CRO EPS Group. Their business model integrates medical research with the commercialization of health foods, cosmetics, and pharmaceutical-grade cannabinoid products.